undamentalytics Newsletter
Sign in

Electrocore, Inc. (ECOR) stock

Add to watchlist

Add holding +

NASDAQ: ECOR Nasdaq Health Care Equipment Next results ~November 4, 2026

C+ Fundamentals grade

Electrocore, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$5.9

Valuation models combined (3)

Base case. Range ~$4.1–$8.6. Weighted average of 3 models (growth cash-flow model, forward price-to-sales vs peers, revenue-to-maturity model), the growth cash-flow model counting double.

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Electrocore, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders3 buying, 2 selling5 purchases and 9 sales by directors and officers, last 12 monthsInsider trades
  • Funds15 adding, 9 cuttingOf 6 active managers that changed their stake, 3 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Electrocore files

Where Electrocore stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $37m, up 33.5% on a year earlier, faster than the 31.9% growth a quarter earlier. That growth ranks 17 of 103 among the health care equipment companies we cover. Free-cash-flow margin rose to -26.4% from -2313.8% a year earlier. Operating margin widened to -37.6% from -47.1%. The diluted share count is up 8.5% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 3 of our 5 financial-health checks. Our revenue-to-maturity cash-flow model value is $8.96 a share.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

Electrocore, Inc.'s trailing-twelve-month revenue grew 33.5% year on year, with a free-cash-flow margin of -26.4%. Where it stands out: days sales outstanding of 9 days ranks 2 of 118 health care equipment companies we cover.

Current signal Gross margin expanding: TTM gross margin reached 87.1%, up 1.5pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 33.5% over the last 12 months, against a median of 9.1% for health care equipment companies we cover.
  • Margins widening. Operating margin is up 9.5 points on a year ago.

Things to watch

  • Loss-making. Operating margin is -37.6%: costs exceed revenue.
  • Burning cash. Free cash flow was -26.4% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 8.5% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 89% and a beta of 1.9 against the S&P 500.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
-$0.33 against an average estimate of -$0.42: beat by 21.8%
Revenue
$9m, up 28.0% on a year earlier
Share reaction
+23.9% in the first session after the results on August 6, 2026, against +0.5% for the S&P 500
Guidance given
full-year 2026 revenue guidance growth 30% (full-year 2026); incentive compensation variable expense as a percentage of prescription revenue 27% (by the end of 2027)
Next report
November 4, 2026

Electrocore's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-4.8%
  • 1 week-3.8%
  • 1 month-29.4%
  • This year+59.6%
  • 1 year+42.1%
  • 5 years-52.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$37M
Operating margin
-37.6%
Net margin
-40.0%
EPS (TTM, diluted)
$-1.66

Growth

Revenue growth
+33.5%
Change in growth rate
+1.6 pts
Share count change
+8.5%

Cash

Free cash flow (TTM)
-$9.7M
FCF margin
-26.4%
Stock pay % of revenue
7.2%

Earnings

Last results
August 6, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Leadership
  2. Results
  3. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Electrocore, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Electrocore, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 9.8%: the 10-year Treasury yield (4.9%) plus a beta of 1.09 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$4.1 ~$1.6–$6.3 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: book value or earnings not available
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$7.4 ~$8.4–$28 Included, half weight
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$8.6 ~$6.5–$11 Included
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$5.9 ~$4.1–$8.6 3 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Electrocore, Inc. with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20182019202020212022202320242025Now
Share price$93.90$23.85$23.40$8.74$3.85$5.95$16.21$4.49$7.16
Market value$2.7bn$701m$913m$34499$18230$33m$121m$38m$64m
+ Net debt (− = net cash)−$8m−$14m−$3m−$35m−$17m−$10m−$4m$727000$261000
Enterprise value$2.7bn$687m$910m−$35m−$17m$23m$118m$39m$64m
Multiples
Price / sales n/mn/mn/m0.0x0.0x2.0x4.8x1.2x1.7x
Price / earnings —————————
Price / free cash flow —————————
EV / EBITDA —————————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

37 /100

Weak moat

How hard Electrocore's competitive advantage looks for rivals to wear away, judged from 9 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -59.6% of total assets over 8 years.

  • Pricing power 12 / 20

    Gross margin has been a median 80.6%, moving by 18.9 percentage points (standard deviation) across 9 years.

  • Durability 10 / 20

    Operating margin has been a median -296.5%; its worst year was -3912.9%.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, after the close. Analysts expect revenue of $11m for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$1.38 +17% $42m +31%
Next −$0.62 +55% $54m +30%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −8.3% on 90 days ago. In the last 30 days, 5 analysts raised Electrocore, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Electrocore, Inc., last 90 days
−$1.50 −$1.00 −$0.50 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$1.50 Current fiscal year, 60 days ago: −$1.50 Current fiscal year, 30 days ago: −$1.48 Current fiscal year, 7 days ago: −$1.40 Current fiscal year, Now: −$1.38 −$1.38 Next fiscal year, 90 days ago: −$0.43 Next fiscal year, 60 days ago: −$0.43 Next fiscal year, 30 days ago: −$0.43 Next fiscal year, 7 days ago: −$0.46 Next fiscal year, Now: −$0.62 −$0.62

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$1.50−$0.43
60 days ago −$1.50−$0.43
30 days ago −$1.48−$0.43
7 days ago −$1.40−$0.46
Now −$1.38−$0.62

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.42 −$0.33 +21.8%
Mar 2026 −$0.61 −$0.59 +3.7%
Dec 2025 −$0.39 −$0.34 +13.4%
Sept 2025 −$0.40 −$0.40 0.0%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 6, 2026
  • full-year 2026 revenue guidance full-year 2026 about 30% growth Raised
    “The Company is raising its full-year 2026 revenue guidance to greater than 30% annual growth over full-year 2025 and expects to achieve positive Adjusted EBITDA in the third quarter of 2027.” source
  • incentive compensation variable expense as a percentage of prescription revenue by the end of 2027 about 27%
    “The redesigned plan realigns the Company's sales territories, eliminating overlapping, inefficient coverage that added cost without building durable accounts and should result in a reduction in incentive compensation variable expense from approximately 35% of prescription revenue to 27% and an overall reduction of the sales and marketing expense to 54% of revenue by the end of 2027.” source
  • sales and marketing expense as a percentage of revenue by the end of 2027 about 54%
    “The redesigned plan realigns the Company's sales territories, eliminating overlapping, inefficient coverage that added cost without building durable accounts and should result in a reduction in incentive compensation variable expense from approximately 35% of prescription revenue to 27% and an overall reduction of the sales and marketing expense to 54% of revenue by the end of 2027.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

5 analysts, Oct 2026
Buy5100%
Hold00%
Sell00%

Monthly trend

  1. Oct 2026145
  2. Sep 2026145
  3. Aug 2026145

Counts of recommendations published by analysts covering Electrocore, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
4.0%
of tradable shares
Days to cover
3.75
at average volume
Short interest, 1 month
+8%
to October 15, 2026
Held by institutions
12%
of shares
Held by insiders
34.2%
of shares
Employees
83
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +42.1%

$5.04 on October 31, 2025 to $7.16

ThenNowEffect
Revenue (last 12 months) $28m $37m +33.5%
P/S multiple 1.5x 1.7x +15.6%
Share count 8m 9m −7.9%

Biggest factor: revenue. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
ECOR−63%−56%+54%+172%−72%+60%
Industry peers (median)−7%−37%−9%−20%−16%−15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
ECOR17%42%67%58%50%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
ECOR−81%−76%−48%−29%−78%−44%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since June 22, 2018: 99% from June 22, 2018 to November 8, 2022. Getting back needed a 9443% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$4.42 – $12.29
From 52-week high
−41.7%
vs 50-day average
−24.1%
vs 200-day average
−7.5%
Volatility (1 year)
89%
Beta vs S&P 500
1.90

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±13.8%
After a week
6 up, 6 down
typical move ±19.9%
After a month
5 up, 7 down
typical move ±19.7%
Results releasedNext dayS&P 500 next day5 days21 days
August 6, 2026 +23.9% +0.5% +52.2% +41.0%
May 6, 2026 −10.3% +1.1% −9.6% +24.7%
March 19, 2026 −9.4% −1.7% −12.8% −8.6%
January 20, 2026 +6.2% −0.9% +10.4% −13.6%
November 5, 2025 +18.0% −0.7% +22.4% −2.6%
August 6, 2025 −28.4% +0.7% −25.1% −28.7%
May 7, 2025 −25.5% +1.1% −33.9% −17.8%
March 12, 2025 −27.5% −0.8% −39.2% −58.1%
January 17, 2025 +1.3% +1.9% +5.0% +23.4%
November 13, 2024 +9.4% −0.6% −20.0% +9.5%
August 7, 2024 +3.6% +1.6% +2.8% +2.2%
May 8, 2024 −2.4% +0.6% +5.4% −6.7%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Electrocore, Inc. in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Electrocore, Inc.
$10M $20M $30M $40M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $13.4M Revenue (TTM), FY23 Q4: $16M Revenue (TTM), FY24 Q1: $18.7M Revenue (TTM), FY24 Q2: $21.3M Revenue (TTM), FY24 Q3: $23.3M Revenue (TTM), FY24 Q4: $25.2M Revenue (TTM), FY25 Q1: $26.5M Revenue (TTM), FY25 Q2: $27.7M Revenue (TTM), FY25 Q3: $29.8M Revenue (TTM), FY25 Q4: $32M Revenue (TTM), FY26 Q1: $34.9M Revenue (TTM), FY26 Q2: $37M $37M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $13.4M
FY23 Q4 $16M
FY24 Q1 $18.7M
FY24 Q2 $21.3M
FY24 Q3 $23.3M
FY24 Q4 $25.2M
FY25 Q1 $26.5M
FY25 Q2 $27.7M
FY25 Q3 $29.8M
FY25 Q4 $32M
FY26 Q1 $34.9M
FY26 Q2 $37M
Revenue growth, TTM YoY Electrocore, Inc.
0% 50% 100% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 78.1% Revenue growth, TTM YoY, FY23 Q4: 86.6% Revenue growth, TTM YoY, FY24 Q1: 97.3% Revenue growth, TTM YoY, FY24 Q2: 95.8% Revenue growth, TTM YoY, FY24 Q3: 74.1% Revenue growth, TTM YoY, FY24 Q4: 57.1% Revenue growth, TTM YoY, FY25 Q1: 41.5% Revenue growth, TTM YoY, FY25 Q2: 30.2% Revenue growth, TTM YoY, FY25 Q3: 27.9% Revenue growth, TTM YoY, FY25 Q4: 27.2% Revenue growth, TTM YoY, FY26 Q1: 31.9% Revenue growth, TTM YoY, FY26 Q2: 33.5% 33.5%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 78.1%
FY23 Q4 86.6%
FY24 Q1 97.3%
FY24 Q2 95.8%
FY24 Q3 74.1%
FY24 Q4 57.1%
FY25 Q1 41.5%
FY25 Q2 30.2%
FY25 Q3 27.9%
FY25 Q4 27.2%
FY26 Q1 31.9%
FY26 Q2 33.5%
Operating margin (TTM) Electrocore, Inc.
-200% -150% -100% -50% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -158.4% Operating margin (TTM), FY23 Q4: -120.2% Operating margin (TTM), FY24 Q1: -90.5% Operating margin (TTM), FY24 Q2: -68.2% Operating margin (TTM), FY24 Q3: -55.9% Operating margin (TTM), FY24 Q4: -48.3% Operating margin (TTM), FY25 Q1: -45.9% Operating margin (TTM), FY25 Q2: -47.1% Operating margin (TTM), FY25 Q3: -44.5% Operating margin (TTM), FY25 Q4: -41.1% Operating margin (TTM), FY26 Q1: -42.0% Operating margin (TTM), FY26 Q2: -37.6% -37.6%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -158.4%
FY23 Q4 -120.2%
FY24 Q1 -90.5%
FY24 Q2 -68.2%
FY24 Q3 -55.9%
FY24 Q4 -48.3%
FY25 Q1 -45.9%
FY25 Q2 -47.1%
FY25 Q3 -44.5%
FY25 Q4 -41.1%
FY26 Q1 -42.0%
FY26 Q2 -37.6%
FCF margin (TTM) Electrocore, Inc.
-6000% -4000% -2000% 0% FY18 Q2 FY18 Q4 FY19 Q2 FY19 Q4 FY26 Q2 FCF margin (TTM), FY18 Q2: -3620.9% FCF margin (TTM), FY18 Q3: -5039.6% FCF margin (TTM), FY18 Q4: -4770.5% FCF margin (TTM), FY19 Q1: -4085.7% FCF margin (TTM), FY19 Q2: -3479.6% FCF margin (TTM), FY19 Q3: -2313.8% FCF margin (TTM), FY19 Q4: -1888.3% FCF margin (TTM), FY25 Q4: -25.8% FCF margin (TTM), FY26 Q1: -19.7% FCF margin (TTM), FY26 Q2: -26.4% -26.4%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY18 Q2 -3620.9%
FY18 Q3 -5039.6%
FY18 Q4 -4770.5%
FY19 Q1 -4085.7%
FY19 Q2 -3479.6%
FY19 Q3 -2313.8%
FY19 Q4 -1888.3%
FY25 Q4 -25.8%
FY26 Q1 -19.7%
FY26 Q2 -26.4%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 1 1 2 3 5 9 16 25 32 37
Gross profit 0 0 1 2 4 7 13 21 28 32
EBITDA −26 −54 −46 −24 −20 −22 −18 −11 −13 −14
Operating income −26 −55 −46 −25 −20 −23 −19 −12 −13 −14
Net income −36 −56 −45 −24 −17 −22 −19 −12 −14 −15
Diluted EPS — −$1.19 −$23.10 −$9.00 −$4.36 −$4.69 −$3.42 −$1.59 −$1.65 −$1.66
Growth (year on year)
Revenue — +22.4% +140.7% +46.3% +55.9% +57.6% +86.6% +57.1% +27.2% +33.5%
Margins
Gross margin 36.1% 41.7% 51.6% 50.3% 74.6% 81.2% 82.5% 85.0% 86.8% 87.1%
EBITDA margin <−999% <−999% <−999% −696.5% −360.7% −259.8% −114.2% −45.3% −39.5% −37.0%
Operating margin <−999% <−999% <−999% −707.9% −367.7% −266.2% −120.2% −48.3% −41.1% −37.6%
Net margin <−999% <−999% <−999% −672.5% −315.9% −257.9% −117.5% −47.2% −43.6% −40.0%
Free-cash-flow margin <−999% <−999% <−999% — — — −92.8% — −25.8% −26.4%
Cash flow
Cash from operations −25 −47 −45 −20 −14 −17 −15 −7 −8 −10
Capital spending 0 0 0 — — — 0 — 0 0
Free cash flow −25 −47 −45 — — — −15 — −8 −10
Stock-based pay 0 8 4 3 3 3 2 2 2 3
Free cash flow after stock pay −26 −55 −49 — — — −17 — −10 −12
Balance sheet
Cash 13 8 14 4 35 18 10 4 7 9
Total debt 0 0 0 1 — 0 0 0 8 9
Net debt (negative = net cash) −13 −8 −14 −3 −35 −17 −10 −4 1 0
Diluted shares — 29m 29m 39m — — 6m 7m 8m 9m

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

3 of 5 checks passed · June 30, 2026
What it owns · $17m
Short-term assets $14mLonger-term assets $3m
What it owes, and who funded it · $20m
Short-term liabilities $12mLonger-term liabilities $8mShareholders' equity $-3m
  • Short-term assets cover short-term liabilities $14m of assets due within a year against $12m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $14m short-term assets against $8m of longer-dated liabilities.
  • More cash than debt $9m of cash against $7m of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$10m of operating cash flow against $7m of debt.
  • Operating profit covers interest at least five times over Operating income of −$14m against $12,700 of interest.

From Electrocore, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+8.5%
year over year
R&D spending
8.5%
of revenue
Sales & admin spending
116.2%
of revenue
Days sales outstanding
9 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care equipment
Last 12 months unless stated ECOR CTSO UTMD RVP OBIO MYO Median
Revenue, last 12 months $37m $37m $36m $34m $32m $43m $99m
Revenue growth, last 12 months 33.5% 3.1% −7.0% −11.2% 986.1% 6.1% 9.2%
Revenue growth, 3-year average 50.4% 0.8% −11.4% −14.7% 94.5% 35.4% 13.5%
Revenue growth, latest quarter 28.0% 0.2% −14.3% −31.1% −89.5% 21.3% 10.2%
Gross margin 87.1% 71.6% 57.9% −1.4% 99.5% 68.4% 61.2%
Operating margin −37.6% −34.7% 28.4% −66.9% −181.4% −27.1% −8.5%
Operating margin, 3-year average −51.0% −49.7% 31.2% −52.5% <−999% −31.6% −17.9%
Net margin −40.0% −48.9% 29.0% −9.9% −184.6% −33.5% −12.0%
Cash from operations / revenue −26.3% −24.6% 32.8% −14.6% −182.4% −16.4% −1.9%
Free-cash-flow margin −26.4% −25.0% 31.7% −37.7% −184.8% −19.2% −3.9%
Free-cash-flow margin, 3-year average <−999% −37.9% 35.4% −20.6% <−999% −31.0% −7.0%
Stock pay / revenue 7.2% 6.1% 1.1% 10.7% 34.8% 6.4% 6.1%
Change in share count 8.5% 4.1% −4.8% 0.0% 58.1% 5.9% 4.0%

Median of all 134 companies we cover in health care equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

134 health care equipment companies
Measure Company Peer median Rank
Revenue growth Growth 33.5% 9.1% 22 of 129
Change in growth rate Growth +1.6pp -0.6pp 36 of 129
Gross margin Profitability 87.1% 61.9% 8 of 123
Operating margin Profitability -37.6% -8.3% 84 of 132
Net margin Profitability -40.0% -12.0% 84 of 133
Free-cash-flow margin Cash generation -26.4% -3.4% 84 of 128
Stock pay as % of revenue Cash generation 7.2% 6.1% 67 of 123
Long-term debt as % of assets Balance sheet 33.8% 24.2% 63 of 87
Change in share count Balance sheet 8.5% 3.3% 81 of 115
Days sales outstanding Balance sheet 9 days 57 days 2 of 118

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$8.9M
Institutions reporting
32
Shares held vs prior quarter
▲ 27.2%
Positions opened / closed
8 / 5

Top buyers and sellers, Q2 2026: 15 institutions bought and 9 sold ; the biggest buyer was Fourworld Capital Management LLC (+94K shares) and the biggest seller Balyasny Asset Management L.P (−116K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Vanguard Capital Management LLC $1.8M 212K 20.6% ▲ 4.4%
Fourworld Capital Management LLC $812,160 94K 9.2% New
Wexford Capital LP $795,398 92K 9.0% New
Geode Capital Management, LLC $632,154 73K 7.1% ▼ 6.3%
Northern Trust Corp $574,612 67K 6.5% ▲ 498.2%
Jane Street Group, LLC $547,793 63K 6.2% New
Wealthspire Advisors, LLC $410,383 47K 4.6% 0.0%
Citadel Advisors LLC $378,457 44K 4.3% New
Marshall Wace, LLP $377,325 44K 4.3% New
Vanguard Fiduciary Trust Co $334,973 39K 3.8% ▲ 0.6%
Hightower Advisors, LLC $305,355 35K 3.4% 0.0%
International Assets Investment Management, LLC $301,041 36K 3.4% ▼ 22.2%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Electrocore, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $212,042 5 trades by 3 insiders, last 12 months Insider sales History → $946,387 9 trades by 2 insiders · 0% under pre-set plans
Net ▼ $734,345 net selling
Insider Date Trade Shares Price Value
Errico Thomas J. Director September 14, 2026 Buy 5,000 $9.82 $49,100
Fox Michael See Remarks September 11, 2026 Buy 5,000 $9.80 $49,000
Lev Joshua S. CFO and Interim President August 25, 2026 Sell 3,000 $9.36 $28,080
Lev Joshua S. CFO and Interim President August 24, 2026 Sell 5,000 $9.88 $49,400
Lev Joshua S. CFO and Interim President August 21, 2026 Sell 12,000 $10.22 $122,640
Errico Thomas J. Director August 13, 2026 Buy 5,000 $9.85 $49,250
Lev Joshua S. CFO and Interim President May 28, 2026 Sell 6,667 $9.00 $60,003
Lev Joshua S. CFO and Interim President May 22, 2026 Sell 3,000 $6.50 $19,500
Errico Thomas J. Director May 21, 2026 Buy 9,992 $5.99 $59,852
Goldberger Daniel S 10% owner April 23, 2026 Sell 80,000 $6.80 $544,000
Goldberger Daniel S 10% owner April 10, 2026 Sell 16,072 $6.02 $96,753
Lev Joshua S. Chief Financial Officer December 4, 2025 Sell 2,500 $5.05 $12,625

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

  • August 6, 2026
  • May 6, 2026
  • March 19, 2026
  • January 20, 2026
  • November 5, 2025
  • August 6, 2025

Recent SEC filings

Data status

When each part of this page on Electrocore, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Electrocore, Inc. in brief

What does Electrocore, Inc. do?
Electrocore, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
What is Electrocore, Inc.'s stock ticker?
Electrocore, Inc. trades under the ticker ECOR on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Electrocore, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Electrocore, Inc. reported revenue of $37M, 33.5% higher than a year earlier, according to its SEC filings.
What is Electrocore, Inc.'s free cash flow?
Electrocore, Inc.'s free-cash-flow margin is -26.4% of revenue over the trailing twelve months, ranking 84 of the 128 health care equipment companies we cover.
Who are Electrocore, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Vanguard Capital Management LLC, Fourworld Capital Management LLC and Wexford Capital LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Electrocore, Inc.'s market cap?
On November 2, 2026, Electrocore, Inc.'s market capitalisation was about $63.9M and net debt of $261,000. Market figures come from third-party market data and may be delayed.
Who are Electrocore, Inc.'s competitors?
In our Health Care Equipment peer group, the companies closest to Electrocore, Inc. are Cytosorbents Corp, Utah Medical Products Inc, Retractable Technologies Inc, Orchestra Biomed Holdings, Inc. and Myomo, Inc. The side-by-side comparison below sets their revenue, margins and growth against Electrocore, Inc.'s.
Are insiders buying or selling Electrocore, Inc. stock?
Over the last 12 months, Electrocore, Inc.'s directors and officers reported 5 open-market purchases and 9 sales on Form 4. The insider trading page charts every trade.
When is Electrocore, Inc.'s next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Electrocore, Inc. announces its own schedule.